Geary Richard S

Avg. Two Year Performance

No purchase track record

(29%) Avg. Sale Return

(14%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	4%	4%	7%	5%	(29%)
Sale Success Rate	14 of 27	13 of 27	14 of 27	9 of 27	8 of 27

ISIS Pharmaceuticals Inc.

Drugs » Drug Manufacturers - Other

EVP, Chief Development Officer:

Holdings: 84.83K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--